IMB reports on EMA statement on use of the Pandemrix vaccine
The Irish Medicines Board (IMB) has reported on the European Medicines Agency’s statement on the use of the Pandemrix vaccine and the onset of narcolepsy. Investigation into cases occurring in Ireland is on-going.
- European Medicines Agency completes review of Pandemrix – IMB 21 July 2011
- European Medicines Agency recommends restricting use of Pandemrix – EMA 21 July 2011
- Q&A on the review of Pandemrix Influenza vaccine – EMA 21 July 2011
- Recommendation by the European Medicines Agency concerning Pandemrix® vaccination and reports of narcolepsy in children and adolescents - ECDC 21 July 2011